Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUP1602-C in Diabetic Foot Ulcers
NCT04281992Phase 2Completed
- Sponsor
- Aurealis Therapeutics
- Start
- Jan 2020
- Primary completion
- Mar 2023
- Modality
- Gene Editing, Gene Silencing, Yeast Strains
- Countries
- 2
01
Overview
A Phase 2 trial of AUP-16 in diabetic foot ulcer (DFU), sponsored by Aurealis Therapeutics. Started Jan 2020; status: completed.
02
Drugs
AUP-16
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04281992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04281992.